Definitive Healthcare Corp.
NASDAQ:DHMedical - Healthcare Information Services
+$0.01 today
- Market cap
- $143.60M
- Beta
- 1.33
- P/E (TTM)
- -0.5
- EPS (TTM)
- -$1.63
Volume 0.43M
Average 0.32M
DH Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Definitive Healthcare Corp.NASDAQ: DH
Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026
Accounts receivables growth accelerates
Q1 FY2026 accounts receivables of $13.26M rose 28.1% year over year, ahead of the -67.1% change in trailing-twelve-month accounts receivables.
Context
- Accounts receivables amounted to 0.6% of revenue in FY2025, down 1.7 pp from a year earlier.
- Accounts receivables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +28.1% holds above the trailing-twelve-month pace of -67.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- 1.38M USD
- Year-over-year change
- -75.7%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.38M | -75.7% |
| FY2024 | 2024-12-31 | 5.69M | +602.0% |
| FY2023 | 2023-12-31 | 811K | +106.1% |
| FY2022 | 2022-12-31 | (13.22M) | -23.3% |
| FY2021 | 2021-12-31 | (10.73M) | — |
Accounts Receivables vs competitors
How DH compares with its peers on the latest reported figures
- DH's LTM Mar 2026 accounts receivables of $4.29M is the largest of the 10 companies compared; the peer median is $0.
- Its year-over-year change of -67.1% is the 5th highest of 8, against a peer median of +27.5%.
- Accounts receivables amounts to 1.8% of revenue for DH, versus a peer median of 0.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $4.29M | -67.1% | — | 1.8% | |
| LTM Mar 2026 | $3.43M | -549.9% | — | 4.2% | |
| LTM Mar 2026 | $2.08M | +685.7% | — | 5.4% | |
| LTM Feb 2026 | $1.68M | +27.5% | -47.2% | 2.1% | |
| LTM Mar 2026 | $622K | -80.6% | -37.3% | 0.2% | |
| LTM Mar 2026 | $534K | -324.4% | +3.6% | 0.4% | |
| LTM Mar 2026 | $494K | +111.1% | -58.3% | 0.4% | |
| LTM Mar 2026 | $11.39K | +122.9% | — | 0.3% | |
| LTM Mar 2026 | $0 | — | — | — | |
| LTM Mar 2026 | $0 | — | — | — | |
| Peer median (excluding DH) | $0 | +27.5% | -42.2% | 0.4% | |
Competitors are the stored peer set for DH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (62.32M) | (22.26M) | (202.39M) | (591.45M) | (199.3M) |
| Depreciation & Amortization | 59.95M | 56.9M | 51.75M | 51.67M | 56.11M |
| Deferred Income Tax | (587K) | (26.67M) | (18.71M) | (119.58M) | (10.88M) |
| Stock-Based Compensation | 9.96M | 36.43M | 48.74M | 38.09M | 29.14M |
| Change in Working Capital | (2.51M) | (21.95M) | (30.39M) | (25.93M) | (9.42M) |
| Accounts Receivables | (10.73M) | (13.22M) | 811K | 5.69M | 1.38M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 3.42M | 358K | 1.33M | (5.46M) | (1.09M) |
| Other Working Capital | 4.79M | (9.09M) | (32.53M) | (26.17M) | (9.71M) |
| Other Non-Cash Items | 20.73M | 13.12M | 192.19M | 705.4M | 188.12M |
| Operating Cash Flow | 25.21M | 35.58M | 41.19M | 58.2M | 53.78M |
| Capital Expenditures | (6.73M) | (8.33M) | (2.98M) | (12.34M) | (16.72M) |
| Acquisitions (Net) | (40M) | (56.3M) | (45.02M) | (13.53M) | 0 |
| Purchases of Investments | 0 | (337.96M) | (259.21M) | (304.3M) | (64.07M) |
| Sales of Investments | 0 | 153.68M | 275.43M | 303.77M | 234.66M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (46.73M) | (248.9M) | (31.78M) | (26.41M) | 153.88M |
| Debt Repayment | (199.46M) | (6.88M) | (8.59M) | (13.75M) | (79.47M) |
| Common Stock Issued | 834.95M | (1.73M) | (30K) | 0 | 0 |
| Common Stock Repurchased | (231.77M) | 0 | 0 | (22.37M) | (49.45M) |
| Dividends Paid | (8.13M) | (12.87M) | (12.28M) | (5.14M) | (3.15M) |
| Other Financing Activities | (11.22M) | (5.22M) | (4.68M) | (15.5M) | (18.72M) |
| Financing Cash Flow | 384.37M | (26.7M) | (25.58M) | (56.75M) | (150.79M) |
| Effect of Forex Changes | (129K) | (544K) | 218K | (636K) | 1.39M |
| Net Change in Cash | 362.72M | (240.56M) | (15.96M) | (25.6M) | 58.25M |
| Free Cash Flow | 18.48M | 27.25M | 38.21M | 45.85M | 37.06M |
Definitive Healthcare Corp.
NASDAQ:DH
Intrinsic Alpha fair value
Locked
Current Price
$1.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.